Furusaka A, Nishiyama M, Ohkawa K, Yamori T, Tsuruo T, Yonezawa K, Kasuga M, Hayashi S, Tanaka T
Department of Internal Medicine (Daisan Hospital), Tokyo, Japan.
Cancer Lett. 1994 Aug 29;84(1):85-92. doi: 10.1016/0304-3835(94)90361-1.
To investigate the expression and subcellular distribution of insulin receptor substrate-1 in hepatocytes, which are major targets of insulin along with muscle and adipose tissue, we obtained monoclonal antibodies by immunizing mice with a fusion protein consisting of the C-terminal portion of the human insulin receptor substrate-1 and glutathione-S-transferase. Two of the monoclonal antibodies (designated as 7B3 and 6G5) were found to be useful for immunohistochemical studies. Using 6G5 we demonstrate a high level of expression of insulin receptor substrate-1 in liver cirrhosis hepatocytes and variable expression in hepatocellular carcinoma cells. These results suggest that insulin receptor substrate-1 may play a role in liver regeneration during cirrhosis and that an insulin signaling cascade may be involved in hepatocarcinogenesis.
为研究胰岛素受体底物-1在肝细胞(与肌肉和脂肪组织一样是胰岛素的主要作用靶点)中的表达及亚细胞分布,我们用包含人胰岛素受体底物-1 C末端部分和谷胱甘肽-S-转移酶的融合蛋白免疫小鼠,获得了单克隆抗体。发现其中两种单克隆抗体(命名为7B3和6G5)可用于免疫组织化学研究。使用6G5,我们证明胰岛素受体底物-1在肝硬化肝细胞中高表达,而在肝癌细胞中表达各异。这些结果表明胰岛素受体底物-1可能在肝硬化期间的肝再生中发挥作用,并且胰岛素信号级联可能参与肝癌发生。